Indeed, Vassilev and colleagues [6] identified the first small molecule inhibitor of MDM2-p53 called nutlin-3a and showed that this MDM2 antagonist can induce cell death in cancer cells with elevated MDM2 in a p53 dependent manner. The gene discussed is TP53; the disease is cancer.